We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+2.9%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
10 Year Est. Return
AUM
$447M
AUM Growth
Cap. Flow
+$452M
Cap. Flow %
101.18%
Top 10 Hldgs %
25.17%
Holding
260
New
260
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$16.4M
2
CELG
Celgene Corp
CELG
+$16.3M
3
AMGN icon
Amgen
AMGN
+$12.9M
4
LUV icon
Southwest Airlines
LUV
+$12.3M
5
AAPL icon
Apple
AAPL
+$10.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 21.33%
2 Consumer Staples 13.46%
3 Industrials 12.37%
4 Energy 9.97%
5 Technology 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
51
MetLife
MET
$62.6B
$2.28M 0.51%
+56,015
New +$2.06M
BXP icon
52
Boston Properties
BXP
$11B
$2.28M 0.51%
+21,625
New +$2.35M
GS icon
53
Goldman Sachs
GS
$308B
$2.28M 0.51%
+15,086
New +$2.3M
RTX icon
54
RTX Corp
RTX
$293B
$2.28M 0.51%
+38,973
New +$2.3M
PAA icon
55
Plains All American Pipeline
PAA
$17.1B
$2.22M 0.5%
+39,700
New +$2.25M
QCOM icon
56
Qualcomm
QCOM
$176B
$2.15M 0.48%
+35,248
New +$2.25M
SLB icon
57
SLB Ltd
SLB
$74.9B
$2.14M 0.48%
+29,927
New +$2.22M
MO icon
58
Altria Group
MO
$126B
$2.07M 0.46%
+59,084
New +$2.12M
QQQ icon
59
Invesco QQQ Trust
QQQ
$446B
$2M 0.45%
+27,997
New +$2M
KRFT
60
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$1.94M 0.43%
+34,768
New +$1.86M
FDX icon
61
FedEx
FDX
$73.7B
$1.92M 0.43%
+19,430
New +$1.89M
MON
62
DELISTED
Monsanto Co
MON
$1.9M 0.42%
+19,193
New +$2.01M
LLY icon
63
Eli Lilly
LLY
$1.08T
$1.88M 0.42%
+38,200
New +$2.08M
HPQ icon
64
HP
HPQ
$25.5B
$1.88M 0.42%
+166,469
New +$1.7M
MGM icon
65
MGM Resorts International
MGM
$11.8B
$1.82M 0.41%
+123,350
New +$1.74M
HD icon
66
Home Depot
HD
$345B
$1.82M 0.41%
+23,508
New +$1.77M
AXP icon
67
American Express
AXP
$227B
$1.82M 0.41%
+24,332
New +$1.73M
META icon
68
Meta Platforms (Facebook)
META
$1.52T
$1.77M 0.4%
+71,295
New +$1.83M
FCX icon
69
Freeport-McMoran
FCX
$89.2B
$1.75M 0.39%
+63,242
New +$1.93M
CVS icon
70
CVS Health
CVS
$138B
$1.74M 0.39%
+30,382
New +$1.76M
IYG icon
71
iShares US Financial Services ETF
IYG
$2.17B
$1.72M 0.39%
+72,240
New +$1.67M
D icon
72
Dominion Energy
D
$62.7B
$1.64M 0.37%
+28,841
New +$1.69M
KMB icon
73
Kimberly-Clark
KMB
$37.8B
$1.56M 0.35%
+16,809
New +$1.62M
MDLZ icon
74
Mondelez International
MDLZ
$80B
$1.52M 0.34%
+53,132
New +$1.62M
VWO icon
75
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$1.48M 0.33%
+38,107
New +$1.6M

Similar funds

Gerald L. Ray & Associates's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Gerald L. Ray & Associates, which disclosed 260 positions worth $447M. Its ten largest holdings account for 25% of the portfolio.

Its largest position is Regeneron Pharmaceuticals: 70,490 shares worth $15.9M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Consumer Staples and Industrials.

  • Gerald L. Ray & Associates's largest Q2 2013 buy was Regeneron Pharmaceuticals: 70,490 shares worth $15.9M.
  • Gerald L. Ray & Associates's ten largest holdings make up 25% of its $447M portfolio in Q2 2013.
  • Gerald L. Ray & Associates disclosed 260 positions in Q2 2013, its first 13F filing on record.

Based on Gerald L. Ray & Associates's 13F filing for Q2 2013, filed 1 Aug 2013.